Pharma channel feed

Com­pounders just lost their case to put obe­si­ty drug tirzepatide back in short­age

3 weeks ago
Law
Health Tech

What Vinay Prasad means for CBER, vac­cines, drug ap­provals and more

3 weeks ago
FDA+

No­vo Nordisk trims growth fore­cast as GLP-1 com­pounder ban yet to go live

3 weeks ago

Sarep­ta’s stock plum­mets af­ter Prasad ap­point­ment, low Ele­v­idys sales

3 weeks ago
FDA+

States sue US over plan for re­or­ga­ni­za­tion of fed­er­al health agen­cies

3 weeks ago
Law

Trump, Con­gress look at match­ing some US drug prices to costs abroad

3 weeks ago

Trump, FDA ze­ro in on for­eign fac­to­ries to give do­mes­tic sites an edge  

3 weeks ago
FDA+
Manufacturing

Eu­rope pledges €500M to at­tract glob­al sci­ence tal­ent

3 weeks ago
People

Ver­tex touts promis­ing first few months of launch for non-opi­oid pain drug Jour­navx

3 weeks ago

New opi­oid da­ta may not be gen­er­al­iz­able, FDA ad­comm says

3 weeks ago
FDA+

FDA ad­comm will re­view Capri­cor's cell ther­a­py for Duchenne mus­cu­lar dy­s­tro­phy

3 weeks ago
Cell/Gene Tx
FDA+

Bris­tol My­ers to lay off over 500 work­ers in New Jer­sey

3 weeks ago
People

Even as ques­tions grow over RFK Jr.'s vac­cine pol­i­cy, BioN­Tech does­n't see ‘near-term’ im­pact

3 weeks ago
R&D
FDA+

White House bud­get re­quest would cut bil­lions at NIH and CDC, add $500M for MA­HA

4 weeks ago
FDA+

FDA with­draws two fi­nal guid­ances, pulls com­pli­ance dead­lines for bone al­lo­graft mak­ers

4 weeks ago
R&D
FDA+

Miss­ing REMS de­lays Cy­to­ki­net­ic­s' heart drug PDU­FA, stock drops

4 weeks ago
FDA+

HHS launch­es $500M uni­ver­sal vac­cine plat­form as RFK Jr. shakes up US vac­cine pol­i­cy

4 weeks ago
Coronavirus

Am­gen says FDA hold is lift­ed on its Phase 1 obe­si­ty can­di­date as Mar­i­Tide en­ters Phase 3

4 weeks ago

FDA ad­comms slat­ed to re­view da­ta on long-term opi­oid use, over­dos­es

4 weeks ago
FDA+

Lil­ly CEO Ricks urges Trump to drop drug tar­iff plan

4 weeks ago
Manufacturing

Mod­er­na, fac­ing rev­enue miss­es and po­lit­i­cal head­winds, dis­ap­points Wall Street

4 weeks ago
R&D

US drug­mak­ers in­creas­ing­ly look abroad for clin­i­cal tri­als as con­fi­dence in FDA wa­vers

4 weeks ago
In Focus

FDA ap­proves Sat­suma's mi­graine nasal spray af­ter re­jec­tion in 2024

4 weeks ago
FDA+

Bio­gen says Leqem­bi sales are im­prov­ing slow­ly fol­low­ing lack­lus­ter launch

4 weeks ago
First page Previous page 1234567 Next page Last page
A service from the Financial Times